CASP3 and hepatocellular carcinoma: Planned in vitro assays using widely accepted HCC cell lines (e.g., HepG2, Huh7, SNU-449) will investigate cytotoxicity, apoptotic induction, and caspase-3/7 activation via MTT, Annexin V/PI, and Caspase-Glo assays.